Advances in the clinical management of patients with acute and chronic spinal cord injury (SCI) have contributed to extended life expectancies; however longevity in those with SCI remains below that of the general population.(1) Reduced longevity in the SCI population has been attributed to increased incidence of age-associated chronic illnesses,(2) premature cardiovascular aging,(3) and increased prevalence of heart disease, stroke (4) and diabetes mellitus, (5) compared to the general population. In fact, cardiovascular disease (CVD) is now a leading cause of morbidity and mortality in the SCI population, which may be amplified due to increased risk factors such as inactivity, chronic inflammation, and impairment in autonomic cardiovascular control. (6) The American Spinal Injury Association (ASIA) impairment scale (AIS) is used to document remaining motor and sensory function following SCI; (7, 8) however, the degree of autonomic nervous system impairment is not considered within this classification schema. (9, 10) That said, impaired autonomic control of the cardiovascular system after SCI results in measurable changes in heart rate (HR) and blood pressure (BP) that loosely reflect the level and completeness of SCI documented using the AIS classification, (11, 12) but may also reflect orthostatic positioning. (6, 12, 13) The impact of these changes in HR and BP on cardiovascular health and longevity is not fully appreciated in the SCI population; however, prior to identifying the consequences of these cardiovascular abnormalities, prevalence rates of HR and BP values which fall outside the expected normal range should be documented.
The International Standards to Document Autonomic Function (post-SCI) initially established guidelines for the assessment of HR and BP abnormalities in 2009, (10) which was updated in 2012, but the thresholds remained consistent. (14) Specifically, bradycardia is defined as a HR ≤ 60 beats/minute (bpm) and tachycardia as a HR ≥ 100 bpm. (14) Hypotension is defined as a systolic BP (SBP) ≤ 90 mmHg and a diastolic BP (DBP) ≤ 60 mmHg; hypertension is SBP ≥ 140 and/or DBP ≥ 90 mmHg. (14) While these definitions comply with standards established in the non-SCI population, due to decentralized cardiovascular control, they may not be appropriate for use in the SCI population. In addition, relatively recent evidence has emerged which associates adverse outcomes in the general population using other HR (15, 16) and BP (17) (18) (19) (20) (21) thresholds. Beyond the clinical consequences of alterations in HR and BP, persons with SCI may experience loss of independence and life quality related to the inability to adequately maintain cardiovascular homeostasis; however, until we gain a better understanding of the prevalence of these abnormalities, the development and testing of effective treatment strategies will not be a priority.
Therefore, the goal of this investigation was to assess HR and BP in veterans with (SCI) and without SCI (non SCI). Similar to a recent report, (6) we hypothesized that level of SCI (i.e., the higher the lesion level the greater the prevalence of abnormal HR and BP recordings) and orthostatic positioning (i.e., increased prevalence of abnormal HR and BP recordings in the seated versus the supine position) would influence the prevalence of HR and BP abnormalities. In addition, we hypothesized that the prevalence of comorbid cardiovascular medical conditions, current smoking status, age and use of prescription anti-hypertensive (anti-HTN) medications would influence the prevalence of HR and BP abnormalities in veterans with and without SCI.
METHODS

Subjects
All investigative procedures were performed at an urban Veterans Affairs Medical Center (VAMC) in a convenience sample of veterans with and without SCI. The subjects were not matched but were recruited based on willingness to volunteer and having met the inclusion criteria. Veterans with and without SCI were approached and asked to participate in the study during their annual physical examination or in a waiting room area prior to being seen for a routine clinical follow-up appointment. None of the subjects was receiving clinical care for an acute illness or infection, which was ascertained via medical history questionnaire and verified in the medical record. Prior to initiating data collection procedures, subjects were asked questions related to their personal characteristics, which included a complete medical history, prescription medication use, and information pertaining to any chronic medical conditions, which wasverified via electronic medical chart review and corrected if needed. Subjects were then transferred to a clinic bed for instrumentation and a period of quiet rest in the supine position prior to data collection. All study procedures were approved by the local IRB. 
VA Author Manuscript
VA Author Manuscript
Data Collection Procedures
Resting HR and BP assessments were measured for 5 minutes in the supine position in all subjects, for 5 minutes while seated in the veterans with SCI and for 5 minutes while standing in the veterans without SCI; data were recorded at minutes 0, 1, 2, 3, 4 & 5 for a maximum of six recordings in each position. Recording of HR and BP assessments were made using an automated sphygmomanometer BP cuff (Dynamap Pro 300, [GE Healthcare, Buckinghamshire, UK]), which was placed around the upper right arm. Data collection began in the supine position for all subjects and once complete subjects were either transferred to their wheelchair (SCI) or were asked to stand (non-SCI).
Operative Definitions
We examined the incidence of a resting HR ≥ 80 bpm among veterans with and without SCI because of the possible association between persistent cardiac acceleration (CA) and vascular degeneration and cardiac mortality. (16, 22, 23) 
Data Analysis
Data were analyzed using SPSS version 21. For purposes of data analysis, veterans with SCI were categorized by the neurological level of lesion with specific reference to sympathetic cardiovascular innervation (SCI status); tetraplegia (tetra: C3-C8), high thoracic (T1-T5) or low thoracic (T7-L2) lesions. Differences among the groups for subject characteristics and baseline hemodynamics were tested using one-way analysis of variance models. Statistical significance for the ANOVA models was set at the p<0.05 level, and were adjusted for multiple comparisons with Tukey HSD. To statistically assess the effect of group categorization, the data were analyzed using binary logistic regression with presence or absence of the specific condition (separate analyses for CA, HYPO, OH & HTN) coded as the dependent variable. Pairwise group differences for these prevalence rates were compared using univariate chi-square analyses. From the resulting logit calculations, prevalence rates (in percentages) were calculated. In addition, following significant omnibus effects in the logistic regression analyses, 95% confidence intervals (CI) were constructed about the respective prevalence rates for each group, (29) and pairwise differences between groups for prevalence rates were assessed using confidence intervals, as previously described. ( 
RESULTS
Two-hundred forty two subjects signed consent to participant, of which 62 veterans with SCI and 160 veterans without SCI completed all study procedures; 15 subjects did not complete testing and 5 were non-veterans. The study population consisted of predominantly male veterans (97%) and ranged in age from 21-88 years. Characteristics of the study groups are presented (Table 1) ; the high thoracic group was significantly younger than the tetra group and body mass (kg) was significantly reduced in the high thoracic compared to the other 3 groups. The duration of injury in our veterans with SCI ranged from 1 to 54 years and 60% of the SCI study group sustained a complete motor injury (AIS A & B). Duration of injury and AIS classification were entered into the logistic regression models for the SCI groups; however, neither variable contributed to the prediction of the cardiovascular abnormalities beyond that explained by SCI status alone.
Resting supine and upright hemodynamics are presented (Figures 1-3 ). These data show that, regardless of orthostatic position, resting HR was significantly reduced in the tetra group compared to the other 3 groups (Figure 1 ). Although supine SBP did not differ among the study groups ( Figure 2A ), upright SBP was reduced in the tetra group compared to the non-SCI and low thoracic groups ( Figure 2B ). In the non-SCI veterans, supine DBP was significantly increased compared to the 3 SCI groups ( Figure 3A ) and upright DBP was increased compared to the tetra and low thoracic groups ( Figure 3B ). Of note, average HR was ≥ 80 bpm while upright in the non-SCI veterans and regardless of orthostatic position in veterans with high thoracic lesions. Further, average DBP was ≤ 70 mmHg while supine in the high thoracic group and regardless of orthostatic position in the tetra group.
Prevalence rates for medical history which is related to the most prevalent cardiovascular conditions is presented (Table 2 ). Current smoking status did not differ among the study groups. However, overall omnibus effects were significant for cardiovascular diagnoses, HTN diagnosis alone and the use of anti-HTN medications. The diagnosis of CVD, which included HTN, diabetes mellitus, high cholesterol, lipids, triglycerides, heart or vascular disease, was lower in high thoracic compared to the other 3 groups; however, this group effect was eliminated with addition of chronological age. The diagnosis of HTN alone was reduced in veterans with high thoracic and cervical lesions compared to the non-SCI and low thoracic veteran groups, use of prescription anti-HTN medications was increased in the low thoracic group compared to the other 3 groups, and was increased in the non-SCI compared to the tetra group.
The probability and omnibus χ 2 effects for HR and BP abnormalities relative to group affiliation is presented (Table 3) . Prevalence rates for HTN and OH did not differ among the study groups. However, the omnibus tests from the binary logistic regression analyses for group differences were statistically significant for CA, systolic and diastolic HYPO. The prevalence of CA was reduced in the tetra group compared to the other 3 groups. The prevalence of systolic HYPO was increased in the tetra group compared to the other three groups, and the prevalence of diastolic HYPO was reduced in non-SCI veterans compared to the 3 groups of veterans with SCI.
To examine the influence of the aforementioned covariates, additional logistic regression models were constructed with the individual covariates included in the models (Table 4) . For all analyses, the covariates were not significant with the exception of age and number of anti-HTN medications in the CA model; however, even with these covariates included in the model, "group" was still a significant predictor of CA (p < 0.01).
DISCUSSION
In this investigation we sought to determine prevalence rates for HR and BP abnormalities in veterans with SCI compared to a veteran cohort without SCI. The data suggest that SCI status, but not AIS classification or duration of injury, contributes to the prevalence of CA, systolic and diastolic HYPO. In addition, SCI status contributed to the reduced prevalence of the diagnosis of HTN and the use of anti-HTN medications in those with higher cord lesions. Although our data suggest that the prevalence of OH, systolic and diastolic HTN did not differ significantly among the groups, regardless of SCI status, the diagnosis of HTN was increased in the non-SCI and low thoracic veteran groups compared to veterans with high cord lesions (above T6).
We have noted increased resting HR in individuals with paraplegia compared to individuals with tetraplegia and non-SCI controls in laboratory observations (31, 32) significantly reduced prevalence of HTN found in our high thoracic group was fully accounted for by age.
Increased prevalence of systolic HYPO in the tetra and high thoracic groups was not surprising and can be attributed to decentralized sympathetic outflow to the vasculature. (12, 13, 43) An unexpected finding was that the prevalence of systolic HYPO was doubled in veterans with low thoracic lesions compared to veterans without SCI and was comparable to the high thoracic group. Level of lesion in the low thoracic group ranged from T7-L1 and systolic HYPO was predominantly in those with lesions at or above T10, in whom sympathetic control of the splanchnic vascular bed would likely be partially decentralized.
Although we found relatively increased use of prescription anti-HTN medications in veterans with low thoracic lesions, this incidence rate did not contribute to the prevalence of systolic HYPO in this group. There is a growing body of literature which suggests that persistently low systolic BP is associated with cognitive dysfunction (18, (44) (45) (46) and mood disorders. (17, 20, 47) We demonstrated that hypotensive individuals with SCI perform more poorly on tasks of memory and attention processing compared to matched (for incidence of traumatic brain injury) normotensive individuals with SCI. (48) In addition, we reported that individuals with SCI, as well as their clinical care providers, were able to ascribe adverse health-related quality of life effects, which stem from persistent hypotension. (49) However, because most individuals with persistently low systolic BP remain asymptomatic, treatment is very rare, and in fact, the present data indicate that although nearly one-third of the SCI population studied had systolic HYPO only 3 patients (1 high thoracic and 2 tetra) were prescribed an anti-HYPO medication.
In addition to systolic HYPO, more than 50% of the SCI population had diastolic HYPO, defined as a DBP ≤ 70 mmHg, regardless of level, AIS classification, or duration of injury; whereas the prevalence of diastolic HYPO was 30% in the non-SCI veterans. A recent study conducted in a large veteran population (n=14,270) documented, via retrospective chart review, increased all-cause mortality after adjusting for comorbidities in veterans with a DBP ≤ 70 mmHg.(21) These investigators reported a higher incidence of diastolic HYPO in their population (49%) compared to our findings in the non-SCI veterans; however their veterans with diastolic HYPO were nearly a decade older (68±9 years) than our non-SCI veterans with diastolic HYPO (59±14 years). (21) Moreover, the prevalence of a diastolic HYPO was increased in all three SCI groups studied (56%) compared to both groups of non-SCI veterans, and the mean age of the diastolic HYPO group among veterans with SCI was 58±14 years. The mortality risk associated with diastolic HYPO in individuals with SCI is not known, but age, cardiovascular diagnoses and prescription anti-HTN medications did not account for group differences in this prevalence rate.
Interestingly, the prevalence of OH did not differ significantly among our study groups, and ranged between 22% (high thoracic) and 36% (tetra). Age did not contribute to the prevalence of OH in our study population; however, the prevalence rate of OH appears to be higher than previously reported in otherwise healthy middle-aged males (12%), (50) regardless of SCI status. This has significant clinical implication because OH is associated with increased morbidity and mortality in otherwise healthy asymptomatic individuals (i.e., those that do not complain of dizziness, lightheadedness, nausea, blurred vision, etc.). (51-58) It should be noted that we reported BP from manual sphymomanometry at the brachial artery; however, a recent report suggests markedly higher prevalence rates for OH using beat-to-beat BP recordings in men 65+ years old. (59) We hypothesized that, due to impaired sympathetic vasomotor tone, veterans with high cord lesion (above T6) would have a relatively low incidence of the diagnosis of HTN compared to veterans with low cord lesions (T7 and below) and those without SCI. The data support our hypothesis in that the diagnosis of CVD in general, and HTN in particular, was reduced, and as a result use of prescription anti-HTN medications was lower, in veterans with spinal cord lesions above T6. A recent paper documented, through medical chart review, the prevalence of HTN diagnosis in veterans without SCI as 68.4% compared to a prevalence of 56.6% in veterans with SCI. (38) We found a similar prevalence of the diagnosis of HTN in our non-SCI veterans, but due to our differentiation of level of injury relative to the origin of sympathetic vasomotor control, our findings in veterans with SCI differ from those reported by Barry et al. (38) Specifically, the incidence of the diagnosis of HTN was higher in our veterans with SCI below T7 (72.7%), but the incidence was significantly lower in those with lesions above T6 (≈22%). It is therefore important to consider level of injury relative to peripheral sympathetic vasomotor control when reporting the incidence of HTN in persons with SCI.
Of interest, two-thirds of the veterans with tetraplegia studied carried the diagnosis of diabetes mellitus, which may have clinical relevance. Twenty years ago our group reported abnormalities in carbohydrate and lipid metabolism in 67% of veterans with tetraplegia (age: 47±2 years) residing in the New York City metropolitan area. (60) In a second publication we reported that 23% of subjects with complete tetraplegia (age: 38±1 years) were diabetic. (61) It should be appreciated that the incidence of DM increases with advancing age, (60) and today, 90% of our veterans with tetraplegia are older than 50; 57% are older than 60.
Study Limitations
A limitation of this study is that there was no assessment of autonomic dysreflexia (AD) in veterans with SCI. The definition of AD includes an increase in BP ≥ 20/10 mmHg, which may be associated with symptoms including pounding headache, profuse sweating and piloerection above lesion. (62) We were unable to assess the prevalence of AD, which stems from an unrestrained outpouring of norepinephrine from the post-synaptic sympathetic ganglia due to noxious or non-noxious stimuli below the level of lesion, because our data were collected in a resting state. However, elevation in resting BP, which we attributed to HTN, may reflect AD, particularly in individuals with high cord lesions. Large variability in BP is a concern in the SCI population, and because our data were calculated from average BP recordings during a single clinical visit, we may have underestimated the prevalence rates of BP and HR abnormalities and we recognize that these data may not adequately reflect overall cardiovascular hemodynamics in our veterans. It should be noted that the groups were recruited from a convenience sample of veterans with and without SCI, and were not matched for demographic data or medical history; therefore group comparisons should be interpreted with caution and extrapolation to the general VA may be inappropriate. In addition, comparisons for the prevalence of cardiovascular diagnoses, 
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VA Author Manuscript VA Author Manuscript medications and cardiovascular abnormalities in the group with high thoracic lesions should be interpreted with caution because of the small sample size and the lower chronological age compared to the other groups. Also, because a greater percentage of veterans without SCI and those with low thoracic lesions were prescribed anti-HTN medications than veterans with high thoracic and cervical lesions, the use of these agents may have served to bias the analyses. Finally, it should be noted that there were too few women in our study population to discern any unique characteristics of gender on prevalence rates for the hemodynamic abnormalities documented.
In conclusion, our data support the notion that SCI status conveys appreciable cardiovascular risk for increased prevalence of CA, systolic and diastolic HYPO. In addition, prevalence of OH appears to be increased in our veterans with and without SCI at an earlier age than previously reported. Because cardiac acceleration and persistent and episodic hypotension are associated with adverse cognitive and mood consequences, as well as increased morbidity and mortality in the general population, the increased prevalence of these conditions in the SCI population should be considered a priority for clinical investigations and in the management of the health and wellbeing of these individuals. These findings provide a foundation for the development of a national registry describing cardiovascular parameters in the veteran population. 
